Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam medicated plaster for painful hallux rigidus
2021-006811-27Phase 4Completed
- Sponsor
- IBSA Group
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of piroxicam in hallux rigidus, sponsored by IBSA Group. Primary endpoint: Proportion of responders for pain while walking at Day 8. Started Apr 2022; status: completed.
02
Drugs
piroxicam
03
Conditions
hallux rigidus
Beyond the preview
Go deeper on 2021-006811-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006811-27.